- Home
- COLL vs AOSL Comparison
COLL vs AOSL Comparison
Compare COLL & AOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- AOSL
- Stock Information
- Founded
- COLL 2002
- AOSL 2000
- Country
- COLL United States
- AOSL United States
- Employees
- COLL N/A
- AOSL N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- AOSL Semiconductors
- Sector
- COLL Health Care
- AOSL Technology
- Exchange
- COLL Nasdaq
- AOSL Nasdaq
- Market Cap
- COLL 910.2M
- AOSL 768.5M
- IPO Year
- COLL 2015
- AOSL 2010
- Fundamental
- Price
- COLL $26.79
- AOSL $19.43
- Analyst Decision
- COLL Strong Buy
- AOSL Buy
- Analyst Count
- COLL 5
- AOSL 3
- Target Price
- COLL $43.60
- AOSL $35.67
- AVG Volume (30 Days)
- COLL 393.2K
- AOSL 679.2K
- Earning Date
- COLL 05-08-2025
- AOSL 05-07-2025
- Dividend Yield
- COLL N/A
- AOSL N/A
- EPS Growth
- COLL 43.56
- AOSL N/A
- EPS
- COLL 1.86
- AOSL N/A
- Revenue
- COLL $631,449,000.00
- AOSL $666,399,000.00
- Revenue This Year
- COLL $19.96
- AOSL $5.32
- Revenue Next Year
- COLL $3.93
- AOSL $6.62
- P/E Ratio
- COLL $14.31
- AOSL N/A
- Revenue Growth
- COLL 11.41
- AOSL 4.12
- 52 Week Low
- COLL $23.23
- AOSL $15.90
- 52 Week High
- COLL $42.29
- AOSL $53.29
- Technical
- Relative Strength Index (RSI)
- COLL 43.80
- AOSL 42.82
- Support Level
- COLL $25.87
- AOSL $15.90
- Resistance Level
- COLL $27.95
- AOSL $19.80
- Average True Range (ATR)
- COLL 1.50
- AOSL 2.00
- MACD
- COLL 0.05
- AOSL 0.30
- Stochastic Oscillator
- COLL 69.33
- AOSL 46.84
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About AOSL Alpha and Omega Semiconductor Limited
Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.